Evidence map›Paper›PMID 20832277›Full record

ArticleBiosensors & bioelectronics2010

A glucose sensor protein for continuous glucose monitoring.

Jithesh V Veetil, Sha Jin, Kaiming Ye

Abstract readEvaluation Study
In one paragraph

Article in Biosensors & bioelectronics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. HNanomaterials (Basel, Switzerland) · 2022
    Article
  4. Review
  5. Review
  6. Fluorescent Nanobiosensors for Sensing Glucose.Sensors (Basel, Switzerland) · 2018
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Fluorescence lifetime imaging microscopy of intracellular glucose dynamics.Journal of diabetes science and technology · 2012
    Article
  16. Review
  17. Article
  18. Recent advances in nanotechnology for diabetes treatment.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jithesh V VeetilBiomedical Engineering Program, College of Engineering, University of Arkansas, 203 Engineering Hall, Fayetteville, AR 72701, USA.
Sha Jin
Kaiming Ye

Funding

A Glucose Nanosensor for Continuous Glucose Monitoring within Living CellsR15EB006378 · NIBIB · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI YE, KAIMING · 2006 to 2006
$208k
NIBIB NIH HHS R15 EB006378
6 · The paper itself

Abstract

In vivo continuous glucose monitoring has posed a significant challenge to glucose sensor development due to the lack of reliable techniques that are non- or at least minimally-invasive. In this proof-of-concept study, we demonstrated the development of a new glucose sensor protein, AcGFP1-GBPcys-mCherry, and an optical sensor assembly, capable of generating quantifiable FRET (fluorescence resonance energy transfer) signals for glucose monitoring. Our experimental data showed that the engineered glucose sensor protein can generate measurable FRET signals in response to glucose concentrations varying from 25 to 800 μM. The sensor developed based on this protein had a shelf-life of up to 3 weeks. The sensor response was devoid of interference from compounds like galactose, fructose, lactose, mannose, and mannitol when tested at physiologically significant concentrations of these compounds. This new glucose sensor protein can potentially be used to develop implantable glucose sensors for continuous glucose monitoring.

Indexed as

Base SequenceBiosensing TechniquesBlood GlucoseBlood Glucose Self-MonitoringDiabetes MellitusDNA PrimersFluorescence Resonance Energy TransferHumansLuminescent ProteinsMicrotechnologyOptical DevicesProtein EngineeringProtein StabilityRecombinant Fusion ProteinsBlood GlucoseDNA PrimersLuminescent ProteinsRecombinant Fusion Proteins

Identifiers

PMID20832277
PMCPMC2997158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.